These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26104826)

  • 1. In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.
    Rodriguez CI; Kegeles LS; Levinson A; Ogden RT; Mao X; Milak MS; Vermes D; Xie S; Hunter L; Flood P; Moore H; Shungu DC; Simpson HB
    Psychiatry Res; 2015 Aug; 233(2):141-7. PubMed ID: 26104826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.
    Simpson HB; Shungu DC; Bender J; Mao X; Xu X; Slifstein M; Kegeles LS
    Neuropsychopharmacology; 2012 Nov; 37(12):2684-92. PubMed ID: 22850733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
    Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR
    Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy.
    Li Y; Zhang CC; Kathrin Weidacker ; Zhang Y; He N; Jin H; Chen W; Voon V; Edden RAE; Yan F
    BMC Psychiatry; 2019 May; 19(1):164. PubMed ID: 31146727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ¹H-[¹³C]-nuclear magnetic resonance spectroscopy measures of ketamine's effect on amino acid neurotransmitter metabolism.
    Chowdhury GM; Behar KL; Cho W; Thomas MA; Rothman DL; Sanacora G
    Biol Psychiatry; 2012 Jun; 71(11):1022-5. PubMed ID: 22169441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between oxidative stress markers and 1H-Magnetic resonance spectroscopy findings in obsessive compulsive disorder.
    Subaşı Turgut F; Bulut M; Hattapoğlu S; Güneş M; Cemal Kaya M; Ekici F; Guli Çetinçakmak M; Kaplan İ; Atmaca M
    Brain Res; 2024 Jun; 1833():148852. PubMed ID: 38494099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.
    Rodriguez CI; Kegeles LS; Levinson A; Feng T; Marcus SM; Vermes D; Flood P; Simpson HB
    Neuropsychopharmacology; 2013 Nov; 38(12):2475-83. PubMed ID: 23783065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T.
    Napolitano A; Shah K; Schubert MI; Porkess V; Fone KC; Auer DP
    Schizophr Bull; 2014 May; 40(3):566-74. PubMed ID: 23671195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy.
    Simpson HB; Kegeles LS; Hunter L; Mao X; Van Meter P; Xu X; Kimeldorf MB; Pearlstein SL; Slifstein M; Shungu DC
    Psychiatry Res; 2015 Apr; 232(1):65-70. PubMed ID: 25715904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.
    Hasler G; van der Veen JW; Tumonis T; Meyers N; Shen J; Drevets WC
    Arch Gen Psychiatry; 2007 Feb; 64(2):193-200. PubMed ID: 17283286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy.
    Dubin MJ; Mao X; Banerjee S; Goodman Z; Lapidus KA; Kang G; Liston C; Shungu DC
    J Psychiatry Neurosci; 2016 Apr; 41(3):E37-45. PubMed ID: 26900793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression.
    Salvadore G; van der Veen JW; Zhang Y; Marenco S; Machado-Vieira R; Baumann J; Ibrahim LA; Luckenbaugh DA; Shen J; Drevets WC; Zarate CA
    Int J Neuropsychopharmacol; 2012 Sep; 15(8):1063-72. PubMed ID: 22040773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial.
    Milak MS; Rashid R; Dong Z; Kegeles LS; Grunebaum MF; Ogden RT; Lin X; Mulhern ST; Suckow RF; Cooper TB; Keilp JG; Mao X; Shungu DC; Mann JJ
    JAMA Netw Open; 2020 Aug; 3(8):e2013211. PubMed ID: 32785636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy.
    Zhu Y; Fan Q; Han X; Zhang H; Chen J; Wang Z; Zhang Z; Tan L; Xiao Z; Tong S; Maletic-Savatic M; Li Y
    J Affect Disord; 2015 Jun; 178():193-200. PubMed ID: 25819113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamatergic abnormalities in the pregenual anterior cingulate cortex in obsessive-compulsive disorder using magnetic resonance spectroscopy: A controlled study.
    Kosová E; Pajuelo D; Greguš D; Brunovský M; Stopková P; Fajnerová I; Horáček J
    Psychiatry Res Neuroimaging; 2023 Oct; 335():111721. PubMed ID: 37832259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.
    Milak MS; Proper CJ; Mulhern ST; Parter AL; Kegeles LS; Ogden RT; Mao X; Rodriguez CI; Oquendo MA; Suckow RF; Cooper TB; Keilp JG; Shungu DC; Mann JJ
    Mol Psychiatry; 2016 Mar; 21(3):320-7. PubMed ID: 26283639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
    Kegeles LS; Mao X; Stanford AD; Girgis R; Ojeil N; Xu X; Gil R; Slifstein M; Abi-Dargham A; Lisanby SH; Shungu DC
    Arch Gen Psychiatry; 2012 May; 69(5):449-59. PubMed ID: 22213769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
    Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive-compulsive disorder: proton magnetic resonance spectroscopy.
    Park SE; Choi NG; Jeong GW
    Acta Neuropsychiatr; 2017 Jun; 29(3):164-169. PubMed ID: 27748207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The right thalamic glutamate level correlates with functional connectivity with right dorsal anterior cingulate cortex/middle occipital gyrus in unmedicated obsessive-compulsive disorder: A combined fMRI and
    Chen Y; Meng Z; Zhang Z; Zhu Y; Gao R; Cao X; Tan L; Wang Z; Zhang H; Li Y; Fan Q
    Aust N Z J Psychiatry; 2019 Mar; 53(3):207-218. PubMed ID: 30354192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.